Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Aims Infective endocarditis (IE) is a life-threatening disease associated with high mortality and morbidity worldwide. We sought to determine how socioeconomic factors might influence its epidemiology, clinical presentation, investigation and management, and outcome, in a large international multicentre registry.Methods and results The EurObservational Programme (EORP) of the European Society of Cardiology EURO-ENDO (European Infective Endocarditis) registry comprises a prospective cohort of 3113 adult patients admitted for IE in 156 hospitals in 40 countries between January 2016 and March 2018. Patients were separated in three groups, according to World Bank economic stratification [group 1: high income (75.6%); group 2: upper-middle income (15.4%); group 3: lower-middle income (9.1%)]. Group 3 patients were younger [median age (interquartile range, IQR): group 1, 66 (53-75) years; group 2, 57 (41-68) years; group 3, 33 (26-43) years; P < 0.001] with a higher frequency of smokers, intravenous drug use, and human immunodeficiency virus infection (all P < 0.001) and presented later [median (IQR) days since symptom onset: group 1, 12 (3-35); group 2, 19 (6-54); group 3, 31 (12-62); P < 0.001] with a higher likelihood of developing congestive heart failure (13.6%, 11.1%, and 22.6%, respectively; P < 0.001) and persistent fever (9.8%, 14.2%, and 27.9%, respectively; P < 0.001). Among 2157 (69.3%) patients with theoretical indication for cardiac surgery, surgery was performed less frequently in group 3 patients (75.5%, 76.8%, and 51.3%, respectively; P < 0.001), who also demonstrated the highest mortality (15.0%, 23.0%, and 23.7%, respectively; P < 0.001).Conclusion Socioeconomic factors influence the clinical profile of patients presenting with IE across the world. Despite younger age, patients from the poorest countries presented with more frequent complications and higher mortality associated with delayed diagnosis and lower use of surgery.
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry / Sengupta, S.P., Prendergast, B., Laroche, C., Furnaz, S., Ronderos, R., Almaghraby, A., Asch, F.M., Blechova, K., Zaky, H., Strahilevitz, J., Dworakowski, R., Miyasaka, Y., Sebag, I., Izumi, C., Axler, O., Jamiel, A., Philip, M., Campos Vieira, M.L., Lancellotti, P., Habib, G., et al.. - In: EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES. - ISSN 2058-5225. - ELETTRONICO. - 9:(2022), pp. 85-96. [10.1093/ehjqcco/qcac012]
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
Sengupta, Shantanu P;Prendergast, Bernard;Laroche, Cécile;Furnaz, Shumaila;Ronderos, Ricardo;Almaghraby, Abdallah;Asch, Federico M;Blechova, Kamila;Zaky, Hosam;Strahilevitz, Jacob;Dworakowski, Rafal;Miyasaka, Yoko;Sebag, Igal;Izumi, Chisato;Axler, Olivier;Jamiel, Abdulrahman;Philip, Mary;Campos Vieira, Marcelo Luiz;Lancellotti, Patrizio;Habib, Gilbert;Argentina:Buenos Aires—I. Granada;M. Mahia;S. Ressi;F. Nacinovich;A. Iribarren;P. Fernandez Oses;G. Avegliano;E. Filipini;Corrientes—R. Obregon;M. Bangher;J. Dho;La Plata: L. Cartasegna;M. L. Plastino;V. Novas;C. Shigel;Florencio Varela—G. Reyes;M. De Santos;N. Gastaldello;M. Granillo Fernandez;M. Potito;G. Streitenberger;P. Velazco;J. H. Casabé;C. Cortes;E. Guevara;F. Salmo;M. Seijo. Austria:Vienna—F. Weidinger;M. Heger;R. Brooks;C. Stöllberger;C. -Y. Ho;L. Perschy;L. Puskas;C. Binder;R. Rosenhek;M. Schneider;M. -P. Winter. Belgium:Liege—E. Hoffer;M. Melissopoulou;E. Lecoq;D. Legrand;S. Jacquet;M. Massoz;L. Pierard;S. Marchetta;R. Dulgheru;C. D´Emal;C. Oury;Jette—S. Droogmans;D. Kerkhove;D. Plein;L. Soens;C. Weytjens;A. Motoc;B. Roosens;I. Lemoine;Edegem—I. Rodrigus;B. Paelinck;B. Amsel;Brussels—P. Unger;D. Konopnicki;C. Beauloye;A. Pasquet;J. L. Vanoverschelde;S. Pierard;D. Vancraeynest;F. Sinnaeve. Brazil:Sao Paulo—J. L. Andrade;K. Staszko;Porto Alegre—R. Dos Santos Monteiro;M. H. Miglioranza;D. L. Shuha;Rio de Janeiro—M. Alcantara;V. Cravo;L. Fazzio;A. Felix;M. Iso;C. Musa;A. P. Siciliano;Marilia—F. Villaca Filho;A. Rodrigues;F. Vilela;J. Braga;R. Silva;D. Rodrigues;L. Silva;S. Morhy;C. Fischer;R. Silva;M. Vieira;T. Afonso;Fortaleza—J. Abreu;S. N. Falcao;V. A. Moises;A. Gouvea;F. J. Mancuso;A. C. Souza;C. Y. Silva;G. João;C. S. Abboud;R. Bellio de Mattos Barretto;A. Ramos;R. Arnoni;J. E. Assef;D. J. Della Togna;D. Le Bihan;L. Miglioli;A. P. Romero Oliveira;R. Tadeu Magro Kroll;D. Cortez;Belo Horizonte—C. L. Gelape;M. d. C. Peirira Nunes;T. C. De Abreu Ferrari. Canada:Ottawa—K. Hay;Montreal—V. Le;M. Page;F. Poulin;C. Sauve;K. Serri;C. Mercure;Quebec—J. Beaudoin;P. Pibarot;I. A. Sebag;L. G. Rudski;G. Ricafort. Croatia:Zagreb: B. Barsic;V. Krajinovic;M. Vargovic;D. Lovric;V. Reskovic-Luksic;J. Vincelj;S. Jaksic Jurinjak;Cyprus:Nicosia—V. Yiannikourides;M. Ioannides;C. Pofaides;V. Masoura;Czech Republic:Ostrava-Poruba—J. Pudich;Prague—A. Linhart;M. Siranec;J. Marek;K. Blechova;M. Kamenik;Hradec Kralove—R. Pelouch;Zlin—Z. Coufal;M. Mikulica;M. Griva;E. Jancova;M. Mikulcova;Olomouc—M. Taborsky;J. Precek;M. Jecmenova;J. Latal;Liberec—J. Widimsky;T. Butta;S. Machacek;Pilsen—R. Vancata;Brno—J. Spinar;M. Holicka. Ecuador:Guayaquil—F. Pow Chon Long;N. Anzules;A. Bajana Carpio;G. Largacha;E. Penaherrera;D. Moreira. Egypt:Mansoura—E. Mahfouz;E. Elsafty;A. Soliman;Y. Zayed;J. Aboulenein;Alexandria—M. Abdel-Hay;A. Almaghraby;M. Abdelnaby;M. Ahmed;B. Hammad;Y. Saleh;H. Zahran;O. Elgebaly;Zagazig—A. Saad;M. Ali;A. Zeid;R. El Sharkawy;Cairo—A. Al Kholy;R. Doss;D. Osama;H. Rizk;A. Elmogy;M. Mishriky. France:Kremlin-Bicêtre— P. Assayag;S. El Hatimi;Marseille: S. Hubert;J. -P. Casalta;F. Gouriet;F. Arregle;S. Cammilleri;L. Tessonnier;A. Riberi;Saint-Etienne—E. Botelho-Nevers;A. Gagneux-Brunon;R. Pierrard;C. Tulane;S. Campisi;J. -F. Fuzellier;M. Detoc;T. Mehalla;Nantes—D. Boutoille;A. S. Lecompte;M. Lefebvre;S. Pattier;O. Al Habash;N. Asseray-Madani;C. Biron;J. Brochard;J. Caillon;C. Cueff;T. Le Tourneau;R. Lecomte;M. M. Magali Michel;J. Orain;S. Delarue;M. Le Bras;Limoges—J. -F. Faucher;V. Aboyans;A. Beeharry;H. Durox;M. Lacoste;J. Magne;D. Mohty;A. David;V. Pradel;Thonon-les-Bains—V. Sierra;A. Neykova;B. Bettayeb;S. Elkentaoui;B. Tzvetkov;G. Landry;Reims—C. Strady;K. Ainine;S. Baumard;C. Brasselet;C. Tassigny;V. Valente-Pires;M. Lefranc;Pointe-à-Pitre—B. Hoen;B. Lefevre;E. Curlier;C. Callier;N. Fourcade;Brest—Y. Jobic;S. Ansard;R. Le Berre;F. Le Ven;M. -C. Pouliquen;G. Prat;P. Le Roux.;Rouen—F. Bouchart;A. Savoure;C. Alarcon;C. Chapuzet;I. Gueit;Amiens—C. Tribouilloy;Y. Bohbot;F. Peugnet;M. Gun;Paris—X. Duval;X. Lescure;E. Ilic-Habensus;Nancy: N. Sadoul;C. Selton-Suty;F. Alla;F. Goehringer;O. Huttin;E. Chevalier;Poitiers—R. Garcia, V. Le Marcis;Rennes—P. Tattevin;E. Flecher;M. Revest;Besançon—C. Chirouze;K. Bouiller;L. Hustache-Mathieu;T. Klopfenstein;J. Moreau;D. Fournier;A. -S. Brunel;Créteil—P. Lim;L. Oliver;J. Ternacle;A. Moussafeur;Dijon—P. Chavanet;L. Piroth;A. Salmon-Rousseau;M. Buisson;S. Mahy;C. Martins;S. Gohier;Noumea—O. Axler;F. Baumann;S. Lebras. Germany:Bad Oeynhausen—C. Piper;D. Guckel;J. Börgermann;D. Horstkotte;E. Winkelmann;B. Brockmeier;Leipzig—D. Grey;Bonn—G. Nickenig;R. Schueler;C. Öztürk;E. Stöhr;Bad Nauheim—C. Hamm;T. Walther;R. Brandt;A. -C. Frühauf;C. T. Hartung;C. Hellner;C. Wild;Aachen—M. Becker;S. Hamada;W. Kaestner;Berlin—K. Stangl;F. Knebel;G. Baldenhofer;A. Brecht;H. Dreger;C. Isner;F. Pfafflin;M. Stegemann;Ludwigshafen—R. Zahn;B. Fraiture;C. Kilkowski;A. -K. Karcher;S. Klinger;H. Tolksdorf. Greece:Athens—D. Tousoulis;C. Aggeli;S. Sideris;E. Venieri;G. Sarri;D. Tsiapras;I. Armenis;A. Koutsiari;G. Floros;C. Grassos;S. Dragasis;L. Rallidis;C. Varlamos;Ioannina—L. Michalis;K. Naka;A. Bechlioulis;A. Kotsia;L. Lakkas;K. Pappas;C. Papadopoulos;S. Kiokas;A. Lioni;S. Misailidou;J. Barbetseas;M. Bonou;C. Kapelios;I. Tomprou;K. Zerva;Voula—A. Manolis;E. Hamodraka;D. Athanasiou;G. Haralambidis;H. Samaras;L. Poulimenos. Hungary:Budapest—A. Nagy;A. Bartykowszki;E. Gara. India:Nagpur—K. Mungulmare;Gurgaon—R. Kasliwal;M. Bansal;S. Ranjan;A. Bhan. Iran:Tehran—M. Kyavar;M. Maleki;F. Noohi Bezanjani;A. Alizadehasl;S. Boudagh;A. Ghavidel;P. Moradnejad;H. R. Pasha;B. Ghadrdoost. Israel:Jerusalem—D. Gilon;J. Strahilevitz;M. Wanounou;S. Israel. Italy:Bari—C. d'Agostino;P. Colonna;L. De Michele;F. Fumarola;M. Stante;Florence—N. Marchionni;V. Scheggi;B. Alterini;S. Del Pace;P. Stefano;C. Sparano;Padova—N. Ruozi;R. Tenaglia;D. Muraru;Grosseto—U. Limbruno;A. Cresti;P. Baratta;M. Solari;Milan—C. Giannattasio;A. Moreo;B. De Chiara;B. Lopez Montero;F. Musca;C. A. Orcese;F. Panzeri;F. Spano;C. F. Russo;O. Alfieri;M. De Bonis;S. Chiappetta;B. Del Forno;M. Ripa;P. Scarpellini;C. Tassan Din;B. Castiglioni;R. Pasciuta;S. Carletti;D. Ferrara;M. Guffanti;G. Iaci;E. Lapenna;T. Nisi;C. Oltolini;E. Busnardo;U. Pajoro;E. Agricola;R. Meneghin;D. Schiavi;Salerno—F. Piscione;R. Citro;R. M. Benvenga;L. Greco;L. Soriente;I. Radano;C. Prota;M. Bellino;D. Di Vece;Genoa—F. Santini;A. Salsano;G. M. Olivieri;Modena—F. Turrini;R. Messora;S. Tondi;A. Olaru;V. Agnoletto;L. Grassi;C. Leonardi;S. Sansoni;Turin—S. Del Ponte;G. M. Actis Dato;A. De Martino. Japan:Nagoya—N. Ohte;S. Kikuchi;K. Wakami;Tsukuba—K. Aonuma;Y. Seo;T. Ishizu;T. Machino-Ohtsuka;M. Yamamoto;N. Iida;H. Nakajima;Tenri—Y. Nakagawa;C. Izumi;M. Amano;M. Miyake;K. Takahashi;Osaka: I. Shiojima;Y. Miyasaka;H. Maeba;Y. Suwa;N. Taniguchi;S. Tsujimoto;Kobe—T. Kitai, M. Ota;Sapporo—S. Yuda, S. Sasaki;Tokyo—N. Hagiwara;K. Yamazaki;K. Ashihara;K. Arai;C. Saitou;S. Saitou;G. Suzuki;Miyazaki—Y. Shibata;N. Watanabe;S. Nishino;K. Ashikaga;N. Kuriyama;K. Mahara;T. Okubo;H. Fujimaki;H. Shitan;H. Yamamoto;K. Abe;M. Terada;S. Takanashi;Tokushima—M. Sata;H. Yamada;K. Kusunose;Y. Saijo;H. Seno;O. Yuichiro;Suita—T. Onishi;F. Sera;S. Nakatani;H. Mizuno;K. Sengoku. Republic of Korea:Seoul—S. W. Park;K. Eun Kyoung;L. Ga Yeon;J-w. Hwang;C. Jin-Oh;S. -J. Park;L. Sang-Chol;C. Sung-A;S. Y. Jang;R. Heo;S. Lee;J. -M. Song;E. Jung. Lithuania:Siauliai—J. Plisiene;A. Dambrauskaite;G. Gruodyte;Kaunas—R. Jonkaitiene;V. Mizariene;J. Atkocaityte;R. Zvirblyte. Luxembourg:Luxembourg—R. Sow;A. Codreanu;T. Staub;C. Michaux;E. C. L. De la Vega;L. Jacobs-Orazi. Malta:Msida—C. Mallia Azzopardi;R. G. Xuereb;T. Piscopo;J. Farrugia;M. Fenech;E. Pllaha;C. Vella;D. Borg;R. Casha. Republic of Moldova:Chisinau—L. Grib;E. Raevschi;A. Grejdieru;D. Kravcenco;E. Prisacari;E. Samohvalov;S. Samohvalov;N. Sceglova;E. Panfile;L. Cardaniuc;V. Corcea;A. Feodorovici;V. Gaina;L. Girbu;P. Jimbei;G. Balan;I. Cardaniuc;I. Benesco;V. Marian;N. Sumarga. Montenegro:Podgorica—B. Bozovic;N. Bulatovic;P. Lakovic;L. Music. Netherlands:Rotterdam—R. Budde;A. Wahadat;T. Gamela;Amsterdam—T. Meijers;Groningen—J. P. Van Melle, V. M. Deursen;Maastricht—H. J. Crijns;S. C. Bekkers;E. C. Cheriex;M. Gilbers;B. L. Kietselaer;C. Knackstedt;R. Lorusso;S. Schalla;S. A. Streukens;Utrecht—S. Chamuleau;M. -J. Cramer;A. Teske;T. Van der Spoel;A. Wind;J. Lokhorst;O. Liesbek;H. Van Heusden;The Hague—W. Tanis;I. Van der Bilt;J. Vriend;H. De Lange-van Bruggen;E. Karijodikoro;R. Riezebos;E. van Dongen;J. Schoep;V. Stolk. Norway:Oslo—J. T. Offstad;J. O. Beitnes;T. Helle-Valle;H. Skulstad;R. Skardal. Pakistan:Karachi—N. Qamar;S. Furnaz;B. Ahmed;M. H. Butt;M. F. Khanzada;T. Saghir;A. Wahid. Poland:Warsaw—T. Hryniewiecki;P. Szymanski;K. Marzec;M. Misztal-Ogonowska;Wroclaw—W. Kosmala;M. Przewlocka-Kosmala;A. Rojek;K. Woznicka;J. Zachwyc;Bialystok—A. Lisowska, M. Kaminska;Lodz—J. D. Kasprzak;E. Kowalczyk;D. F. Strzecka;P. Wejner-Mik. Portugal:Carnaxide—M. Trabulo;P. Freitas;S. Ranchordas;G. Rodrigues;Guilhufe—P. Pinto;C. Queiros;J. Azevedo;L. Marques;D. Seabra;Lisbon—L. Branco;J. Abreu;M. Cruz;A. Galrinho;R. Moreira;P. Rio;A. T. Timoteo;M. Selas;V. Carmelo;B. Duque Neves;Almada—H. Pereira;A. Guerra;A. Marques;I. Pintassilgo. Romania:Timisoara—M. C. Tomescu;N. -M. Trofenciuc;M. Andor;A. Bordejevic;H. S. Branea;F. Caruntu;L. A. Velcean;A. Mavrea;M. F. Onel;T. Parvanescu;D. Pop;A. L. Pop-Moldovan;M. I. Puticiu;L. Cirin;I. M. Citu;C. A. Cotoraci;D. Darabantiu;R. Farcas;I. Marincu;A. Ionac;D. Cozma;C. Mornos;F. Goanta;I. Popescu;Cluj-Napoca—R. Beyer;R. Mada;R. Rancea;R. Tomoaia;H. Rosianu;C. Stanescu. Russian Federation:Moscow—Z. Kobalava;J. Karaulova;E. Kotova;A. Milto;A. Pisaryuk;N. Povalyaev;M. Sorokina. Saudi Arabia:Jeddah—J. Alrahimi;A. Elshiekh;Riyadh—A. Jamiel;A. Ahmed;N. Attia. Serbia:Belgrade—B. Putnikovic;A. Dimic;B. Ivanovic;S. Matic;D. Trifunovic;J. Petrovic;D. Kosevic;I. Stojanovic;I. Petrovic;P. Dabic;P. Milojevic;Sremska Kamenica—I. Srdanovic;S. Susak;L. Velicki;A. Vulin;M. Kovacevic;A. Redzek;M. Stefanovic. Singapore:Singapore—T. C. Yeo;W. KF Kong;K. K. Poh. Spain:Madrid—I. Vilacosta;C. Ferrera;C. Olmos;M. Abd El- Nasser;Vigo-Pontevedra—F. Calvo Iglesias;E. Blanco-Gonzalez;M. Bravo Amaro;E. Lopez-Rodriguez;J. Lugo Adan;A. N. Germinas;P. Pazos-Lopez;M. Pereira Loureiro;M. T. Perez;S. Raposeiras-Roubin;S. Rasheed Yas;M. -M. Suarez-Varela;F. Vasallo Vidal;Barcelona—D. Garcia-Dorado;N. Fernandez-Hidalgo;T. Gonzalez-Alujas;J. Lozano;O. Maisterra;N. Pizzi;R. Rios;Badalona—A. Bayes-Genis;L. Pedro Botet;N. Vallejo;C. Llibre;L. Mateu;R. Nunez;D. Quesada;E. Berastegui;Girona—D. Bosch Portell;J. Aboal Vinas;X. Albert Bertran;R. Brugada Tarradellas;P. Loma-Osorio Ricon;C. Tiron de Llano;Valencia—M. A. Arnau;A. Bel;M. Blanes;A. Osa;Cordoba—M. Anguita;F. Carrasco;J. C. Castillo;J. L. Zamorano;J. L. Moya Mur;M. Alvaro;C. Fernandez-Golfin;J. M. Monteagudo;E. Navas Elorza;Santander—M. C. Farinas Alvarez;J. Aguero Balbin;J. Zarauza;J. F. Gutierrez-Diez;C. Arminanzas;F. Arnaiz de las Revillas;A. Arnaiz Garcia;M. Cobo Belaustegui;M. Fernandez Sampedro;M. Gutierrez Cuadra;L. Garcia Cuello;C. Gonzalez Rico;Barakaldo—R. Rodriguez-Alvarez;J. Goikoetxea;M. Montejo;J. M. Miro;M. Almela;J. Ambrosioni;A. Moreno;E. Quintana;E. Sandoval;A. Tellez;J. M. Tolosana;B. Vidal;C. Falces;D. Fuster;C. Garcia-de-la-Maria;M. Hernandez-Meneses;J. Llopis;F. Marco;I. Ruiz-Zamora;Tarragona—A. Bardaji Ruiz;E. Sanz Girgas;G. Garcia-Pardo;M. Guillen Marzo;A. Rodriguez Oviedo;A. Villares Jimenez. Tunisia:Sfax—L. Abid;R. Hammami;S. Kammoun;Tunis—M. S. Mourali;F. Mghaieth Zghal;M. Ben Hlima;S. Boudiche;S. Ouali;La Marsa—L. Zakhama;S. Antit;I. Slama. Turkey:Samsun—O. Gulel;M. Sahin;Ankara—L. E. Sade, E. Karacaglar;Istanbul—S. Kucukoglu;O. Cetinarslan;U. Y. Sinan;U. Canpolat;B. Mutlu;H. Atas;R. Dervishova;C. Ileri. United Arab Emirates:Dubai—J. Alhashmi;J. Tahir;P. Zarger;F. Baslib. United Kingdom:London—S. Woldman;L. Menezes;C. Primus;R. Uppal;I. Bvekerwa;Swindon—B. Chandrasekaran;A. Kopanska;J. Chambers;J. Hancock;J. Klein;R. Rajani;M. P. Ursi;S. Cannata;R. Dworakowski;A. Fife;J. Breeze;M. Browne-Morgan;M. Gunning;S. Streather. United States:Washington—F. M. Asch;M. Zemedkun. Uzbekistan:Tashkent—B. Alyavi;J. Uzokov.
2022
Abstract
Aims Infective endocarditis (IE) is a life-threatening disease associated with high mortality and morbidity worldwide. We sought to determine how socioeconomic factors might influence its epidemiology, clinical presentation, investigation and management, and outcome, in a large international multicentre registry.Methods and results The EurObservational Programme (EORP) of the European Society of Cardiology EURO-ENDO (European Infective Endocarditis) registry comprises a prospective cohort of 3113 adult patients admitted for IE in 156 hospitals in 40 countries between January 2016 and March 2018. Patients were separated in three groups, according to World Bank economic stratification [group 1: high income (75.6%); group 2: upper-middle income (15.4%); group 3: lower-middle income (9.1%)]. Group 3 patients were younger [median age (interquartile range, IQR): group 1, 66 (53-75) years; group 2, 57 (41-68) years; group 3, 33 (26-43) years; P < 0.001] with a higher frequency of smokers, intravenous drug use, and human immunodeficiency virus infection (all P < 0.001) and presented later [median (IQR) days since symptom onset: group 1, 12 (3-35); group 2, 19 (6-54); group 3, 31 (12-62); P < 0.001] with a higher likelihood of developing congestive heart failure (13.6%, 11.1%, and 22.6%, respectively; P < 0.001) and persistent fever (9.8%, 14.2%, and 27.9%, respectively; P < 0.001). Among 2157 (69.3%) patients with theoretical indication for cardiac surgery, surgery was performed less frequently in group 3 patients (75.5%, 76.8%, and 51.3%, respectively; P < 0.001), who also demonstrated the highest mortality (15.0%, 23.0%, and 23.7%, respectively; P < 0.001).Conclusion Socioeconomic factors influence the clinical profile of patients presenting with IE across the world. Despite younger age, patients from the poorest countries presented with more frequent complications and higher mortality associated with delayed diagnosis and lower use of surgery.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1394552
Citazioni
14
28
29
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.